Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kari L Ring

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Case Reports in Obstetrics and Gynecology|February 27, 2026
Incidental Intraplacental Choriocarcinoma in the Setting of Intrauterine Fetal DemiseDavid K Carlson, Gabrielle K Smith, Robin D LeGallo, et al.
Gynecologic Oncology|February 25, 2017
Potential immunotherapy targets in recurrent cervical cancerKari L Ring, Anna V Yemelyanova, Pamela T Soliman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 4, 2020
MHC class I loss in endometrial carcinoma: a potential resistance mechanism to immune checkpoint inhibitionLisa A Friedman, Timothy N Bullock, Emily A Sloan, et al.
Gynecologic Oncology Reports|February 19, 2019
Evaluation of screening and risk-reducing surgery for women followed in a high-risk breast/ovarian cancer clinic: it is all about the tubes in BRCA mutation carriersMartha E Stewart, Anne T Knisely, Mackenzie W Sullivan, et al.
American Journal of Obstetrics and Gynecology|April 29, 2009
Extended-field radiation therapy with whole pelvis radiotherapy and cisplatin chemosensitization in the treatment of IB2-IIIB cervical carcinoma: a retrospective reviewKari L Ring, Jennifer L Young, Neal E Dunlap, et al.
The American Journal of Surgical Pathology|April 23, 2024
Yolk Sac Differentiation in Endometrial Carcinoma: Incidence and Clinicopathologic Features of Somatically Derived Yolk Sac Tumors Versus Carcinomas With Nonspecific Immunoexpression of Yolk Sac MarkersAnne M Mills, Taylor M Jenkins, Megan E Dibbern, et al.
Familial Cancer|April 18, 2019
Genetic counseling referral for ovarian cancer patients: a call to actionChristine Garcia, Kara Harrison, Kari L Ring, et al.
The American Journal of Surgical Pathology|February 23, 2022
Mesonephric-like Endometrial Carcinoma: Results From Immunohistochemical Screening of 300 Endometrial Carcinomas and Carcinosarcomas for This Often Overlooked and Potentially Aggressive EntityAnne M Mills, Taylor M Jenkins, Brooke E Howitt, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 5, 2013
Women 50 years or younger with endometrial cancer: the argument for universal mismatch repair screening and potential for targeted therapeuticsKari L Ring, Elizabeth V Connor, Kristen A Atkins, et al.
BJA Open|May 6, 2026
Perioperative thrombin generation and fibrinolytic activation in patients undergoing major gynaecologic surgery for benign and malignant pathology: a pilot studyEryn L Thiele, Katherine T Forkin, Kari L Ring, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Case Reports in Obstetrics and Gynecology|February 27, 2026
Incidental Intraplacental Choriocarcinoma in the Setting of Intrauterine Fetal DemiseDavid K Carlson, Gabrielle K Smith, Robin D LeGallo, et al.
Gynecologic Oncology|February 25, 2017
Potential immunotherapy targets in recurrent cervical cancerKari L Ring, Anna V Yemelyanova, Pamela T Soliman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 4, 2020
MHC class I loss in endometrial carcinoma: a potential resistance mechanism to immune checkpoint inhibitionLisa A Friedman, Timothy N Bullock, Emily A Sloan, et al.
Gynecologic Oncology Reports|February 19, 2019
Evaluation of screening and risk-reducing surgery for women followed in a high-risk breast/ovarian cancer clinic: it is all about the tubes in BRCA mutation carriersMartha E Stewart, Anne T Knisely, Mackenzie W Sullivan, et al.
American Journal of Obstetrics and Gynecology|April 29, 2009
Extended-field radiation therapy with whole pelvis radiotherapy and cisplatin chemosensitization in the treatment of IB2-IIIB cervical carcinoma: a retrospective reviewKari L Ring, Jennifer L Young, Neal E Dunlap, et al.
The American Journal of Surgical Pathology|April 23, 2024
Yolk Sac Differentiation in Endometrial Carcinoma: Incidence and Clinicopathologic Features of Somatically Derived Yolk Sac Tumors Versus Carcinomas With Nonspecific Immunoexpression of Yolk Sac MarkersAnne M Mills, Taylor M Jenkins, Megan E Dibbern, et al.
Familial Cancer|April 18, 2019
Genetic counseling referral for ovarian cancer patients: a call to actionChristine Garcia, Kara Harrison, Kari L Ring, et al.
The American Journal of Surgical Pathology|February 23, 2022
Mesonephric-like Endometrial Carcinoma: Results From Immunohistochemical Screening of 300 Endometrial Carcinomas and Carcinosarcomas for This Often Overlooked and Potentially Aggressive EntityAnne M Mills, Taylor M Jenkins, Brooke E Howitt, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 5, 2013
Women 50 years or younger with endometrial cancer: the argument for universal mismatch repair screening and potential for targeted therapeuticsKari L Ring, Elizabeth V Connor, Kristen A Atkins, et al.
BJA Open|May 6, 2026
Perioperative thrombin generation and fibrinolytic activation in patients undergoing major gynaecologic surgery for benign and malignant pathology: a pilot studyEryn L Thiele, Katherine T Forkin, Kari L Ring, et al.
Pageof 6